湯臣倍健(300146.SZ):希望未來3-5年內銷售費用率能夠向35%-40%過渡
格隆匯11月7日丨湯臣倍健(300146.SZ)於2023年11月6日接受特定對象調研,就“公司今年銷售費用有所提升,如何展望未來的銷售費用率”,公司回覆稱,銷售費用率水平與公司所處行業賽道及行業發展階段等相關。近年來公司銷售費用率上升一是由於線上渠道收入佔比提升帶動銷售費用率提升,二是由於公司實施“多品牌大單品全品類全渠道單聚焦”戰略,不斷加大品牌建設費用。隨着公司運營能力的逐步提升,銷售費用仍有優化空間,希望未來3-5年內銷售費用率能夠向35%-40%過渡。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.